Vista AI – Intelligent Software that Automates MRI Scanning
What You Should Know
Vista AI, a provider of automated MRI scanning software for hospitals and imaging centers secures $29.5M in Series B financing, backed by a…
Continue Reading
Women’s health issues will be among the priorities for the NHS’s online hospital which is expected to launch in 2027.
Menopause and menstrual problems which may be a sign of endometriosis or fibroids, are among…
Dr Oliver Hulson, consultant radiologist at Leeds Teaching Hospitals NHS Trust (LTHT) who is leading the trial in Leeds (Credit: LTHT)
An AI-powered service for prostate cancer which can spot lesions in minutes will…
Continue Reading
Kevin Coady, Business Leader for Disease Management Solutions & Digital Pathology at Philips North America
Understanding Prostate Cancer: Not All Are the Same
Prostate cancer is the second most common cancer in men, but what many…
Continue Reading
What You Should Know:
– Oatmeal Health and Coreline Soft, a publicly traded leader in AI imaging from South Korea and the U.S., have partnered to co-develop and distribute AI-powered lung cancer screening solutions across…
Continue Reading
Cancer Awareness Trust is launching a platform in the UK to support people affected by cancer, designed in partnership with digital product studio, ustwo.
The Cancer Platform will first be piloted with prostate and breast…
Prostate cancer (PCa) ranks among the most prevalent cancers in men worldwide. Biochemical recurrence (BCR) presents a major clinical challenge in PCa management, with significant prognostic heterogeneity observed among patients post-recurrence. This study aimed…
Continue Reading
What You Should Know:
– Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ArteraAI…
Continue Reading
Existing prostate cancer monitoring methods, reliant on prostate-specific antigen (PSA) measurements in blood tests often fail to detect tumor growth. We develop a computational framework to reconstruct tumor growth from the PSA integrating physics-based…
Continue Reading
An AI-powered tool designed for prostate cancer detection, QP-Prostate by Quibim, has been selected for rollout across seven NHS hospitals in England.
This two-year initiative, announced on July 9, 2025, aims to enhance early diagnosis…
